LifeStance Health Group I... (LFST)
NASDAQ: LFST
· Real-Time Price · USD
5.83
-0.02 (-0.34%)
At close: May 13, 2025, 10:36 AM
-0.34% (1D)
Bid | 5.82 |
Market Cap | 2.27B |
Revenue (ttm) | 1.25B |
Net Income (ttm) | -57.44M |
EPS (ttm) | -0.09 |
PE Ratio (ttm) | -64.72 |
Forward PE | n/a |
Analyst | Buy |
Ask | 5.83 |
Volume | 209,152 |
Avg. Volume (20D) | 1,890,978 |
Open | 5.83 |
Previous Close | 5.85 |
Day's Range | 5.74 - 5.85 |
52-Week Range | 4.64 - 8.61 |
Beta | 1.30 |
About LFST
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LFST
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LFST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
LifeStance Health has released their quartely earnings
on May 7, 2025:
5 days ago
-15.88%
LFST stock has given up its prior gain. LifeStance...
Unlock content with
Pro Subscription
6 days ago
-15.88%
LifeStance Health Group shares are trading higher after the company reported better-than-expected Q1 sales results.

2 weeks ago · seekingalpha.com
LifeStance Health Group: Solid Execution Drives Growth And Margin ExpansionI remain bullish on LifeStance Health Group stock due to robust demand, clinician retention, and margin expansion potential, despite recent share price declines. LFST's flexible hybrid care model and ...

2 months ago · seekingalpha.com
LifeStance Health Group, Inc. (LFST) Q4 2024 Earnings Call TranscriptLifeStance Health Group, Inc. (NASDAQ:LFST ) Q4 2024 Earnings Conference Call February 27, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ken Burdick - CEO David Bourdon - CFO Conferenc...